Health Care & Life Sciences » Pharmaceuticals | Mangalam Drugs & Organics Ltd.

Mangalam Drugs & Organics Ltd. | Cash Flow

Fiscal year is April-March. All values INR Thousands.
2014
2015
2016
2017
2018
Net Income before Extraordinaries
39,063.00
60,088.00
240,160.00
333,824.00
-
Depreciation, Depletion & Amortization
40,105.00
41,541.00
44,130.00
52,439.00
-
Other Funds
664.00
97.00
37,782.00
65,463.00
-
Funds from Operations
378.00
101,726.00
246,508.00
320,800.00
264,578.00
Changes in Working Capital
22,876.00
64,811.00
121,107.00
1,948.00
-
Net Operating Cash Flow
22,498.00
36,915.00
125,401.00
322,748.00
-
Capital Expenditures
23,025.00
38,160.00
110,931.00
395,281.00
-
Sale of Fixed Assets & Businesses
250.00
200.00
1,881.00
646.00
-
Purchase/Sale of Investments
53.00
610.00
1.00
38.00
-
Net Investing Cash Flow
22,722.00
38,570.00
109,049.00
394,673.00
-
Issuance/Reduction of Debt, Net
45,364.00
7,426.00
181,018.00
63,820.00
-
Net Financing Cash Flow
45,364.00
7,426.00
18,193.00
73,245.00
-
Net Change in Cash
144.00
5,771.00
1,841.00
1,320.00
-
Free Cash Flow
45,523.00
1,245.00
14,470.00
72,533.00
-
Change in Capital Stock
-
-
162,825.00
9,425.00
-

About Mangalam Drugs & Organics

View Profile
Address
Rupam Building
Mumbai Maharashtra 400001
India
Employees -
Website http://www.mangalamdrugs.com
Updated 09/14/2018
Mangalam Drugs & Organics Ltd. engages in the manufacture of drugs, medicines and allied products. Its products include Allopurinol, Amodiaquin, Dichloroquinoline, Menthol, Lumefantrine, Amodiaquine Hydrochloride and Artemether. The company was founded in 1977 and is headquartered in Mumbai, India.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.